Skip to main content
SpringerLink
Log in

Chemotherapy in the Treatment of Extensive-Stage Small Cell Lung Cancer

  • Chapter
Lung Cancer

Part of the book series: M.D. Anderson Cancer Care Series ((MDCCS))

  • 253 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  • Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol 1999;17:1794–1801.

    CAS  PubMed  Google Scholar 

  • Clark R, Ihde DC. Small-cell lung cancer: treatment progress and prospects. Oncology (Huntingt) 1998;12:647–658; discussion 661–663.

    CAS  Google Scholar 

  • De Vore RFI, Johnson DH. Chemotherapy for small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, et al, eds. Lung Cancer: Principles and Practice. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:923–939.

    Google Scholar 

  • Elias A. Hematopoietic stem cell transplantation for small cell lung cancer. Chest 1999;116(suppl 6):531S–538S.

    Article  CAS  PubMed  Google Scholar 

  • Evans WK, Feld R, Murray N, et al. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med 1987;107:451–458.

    CAS  PubMed  Google Scholar 

  • Evans WK, Osaba D, Feld R, et al. Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. J Clin Oncol 1985;3:65–71.

    CAS  PubMed  Google Scholar 

  • Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991;83:855–861.

    CAS  PubMed  Google Scholar 

  • Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996;348:563–566.

    Article  CAS  PubMed  Google Scholar 

  • Green RA, Humphrey E, Close H, et al. Alkylating agents in bronchogenic carcinoma. Am J Med 1969;46:516–525.

    Article  CAS  PubMed  Google Scholar 

  • Huisman C, Postmus PE, Giaccone G, et al. Second-line chemotherapy and its evaluation in small cell lung cancer. Cancer Treat Rev 1999;25:199–206.

    Article  CAS  PubMed  Google Scholar 

  • Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992;327:1434–1441.

    Article  CAS  PubMed  Google Scholar 

  • Ihde DC, Mulshine JL, Kramer BS, et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 1994;12:2022–2034.

    CAS  PubMed  Google Scholar 

  • Johnson DH. Management of small cell lung cancer: current state of the art. Chest 1999;116(suppl 6):525S–530S.

    Article  CAS  PubMed  Google Scholar 

  • Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000;117(4 suppl 1):156S–162S.

    Article  CAS  PubMed  Google Scholar 

  • Klasa RJ, Murray N, Coldman AJ. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 1991;9:499–508.

    CAS  PubMed  Google Scholar 

  • Murren J, Glatstein E, Pass HI. Small cell lung cancer. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:983–1018.

    Google Scholar 

  • Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992;10:282–291.

    CAS  PubMed  Google Scholar 

  • Sandler AB. Current management of small cell lung cancer. Semin Oncol 1997;24:463–476.

    CAS  PubMed  Google Scholar 

  • Schiller JH, Adak S, Cella D, et al. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593—a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:2114–2122.

    CAS  PubMed  Google Scholar 

  • Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997;89:577–580.

    Article  CAS  PubMed  Google Scholar 

  • von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999;17:658–667.

    Google Scholar 

Download references

Authors
  1. George R. Blumenschein Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Frank V. Fossella MD

  2. Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Ritsuko Komaki MD

  3. Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030-4009, USA

    Joe B. Putnam Jr. MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Blumenschein, G.R. (2003). Chemotherapy in the Treatment of Extensive-Stage Small Cell Lung Cancer. In: Fossella, F.V., Komaki, R., Putnam, J.B. (eds) Lung Cancer. M.D. Anderson Cancer Care Series. Springer, New York, NY. https://doi.org/10.1007/0-387-22652-4_11

Download citation

  • DOI: https://doi.org/10.1007/0-387-22652-4_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95507-0

  • Online ISBN: 978-0-387-22652-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation